616 related articles for article (PubMed ID: 24252657)
1. ABCG5/ABCG8 in cholesterol excretion and atherosclerosis.
Yu XH; Qian K; Jiang N; Zheng XL; Cayabyab FS; Tang CK
Clin Chim Acta; 2014 Jan; 428():82-8. PubMed ID: 24252657
[TBL] [Abstract][Full Text] [Related]
2. Hepatic expression of ABC transporters G5 and G8 does not correlate with biliary cholesterol secretion in liver transplant patients.
Geuken E; Visser DS; Leuvenink HG; de Jong KP; Peeters PM; Slooff MJ; Kuipers F; Porte RJ
Hepatology; 2005 Nov; 42(5):1166-74. PubMed ID: 16250035
[TBL] [Abstract][Full Text] [Related]
3. Association of ABCG5 and ABCG8 Transporters with Sitosterolemia.
Bydlowski SP; Levy D
Adv Exp Med Biol; 2024; 1440():31-42. PubMed ID: 38036873
[TBL] [Abstract][Full Text] [Related]
4. Scavenger receptor class B type I mediates biliary cholesterol secretion independent of ATP-binding cassette transporter g5/g8 in mice.
Wiersma H; Gatti A; Nijstad N; Oude Elferink RP; Kuipers F; Tietge UJ
Hepatology; 2009 Oct; 50(4):1263-72. PubMed ID: 19637290
[TBL] [Abstract][Full Text] [Related]
5. ABCG5 and ABCG8 are obligate heterodimers for protein trafficking and biliary cholesterol excretion.
Graf GA; Yu L; Li WP; Gerard R; Tuma PL; Cohen JC; Hobbs HH
J Biol Chem; 2003 Nov; 278(48):48275-82. PubMed ID: 14504269
[TBL] [Abstract][Full Text] [Related]
6. Abcg5/Abcg8-independent pathways contribute to hepatobiliary cholesterol secretion in mice.
Plösch T; van der Veen JN; Havinga R; Huijkman NC; Bloks VW; Kuipers F
Am J Physiol Gastrointest Liver Physiol; 2006 Sep; 291(3):G414-23. PubMed ID: 16614371
[TBL] [Abstract][Full Text] [Related]
7. Hepatic ABCG5 and ABCG8 overexpression increases hepatobiliary sterol transport but does not alter aortic atherosclerosis in transgenic mice.
Wu JE; Basso F; Shamburek RD; Amar MJ; Vaisman B; Szakacs G; Joyce C; Tansey T; Freeman L; Paigen BJ; Thomas F; Brewer HB; Santamarina-Fojo S
J Biol Chem; 2004 May; 279(22):22913-25. PubMed ID: 15044450
[TBL] [Abstract][Full Text] [Related]
8. Relation between hepatic expression of ATP-binding cassette transporters G5 and G8 and biliary cholesterol secretion in mice.
Kosters A; Frijters RJ; Schaap FG; Vink E; Plösch T; Ottenhoff R; Jirsa M; De Cuyper IM; Kuipers F; Groen AK
J Hepatol; 2003 Jun; 38(6):710-6. PubMed ID: 12763362
[TBL] [Abstract][Full Text] [Related]
9. Hepatic ABCG5/G8 overexpression substantially increases biliary cholesterol secretion but does not impact in vivo macrophage-to-feces RCT.
Dikkers A; de Boer JF; Groen AK; Tietge UJ
Atherosclerosis; 2015 Dec; 243(2):402-6. PubMed ID: 26520893
[TBL] [Abstract][Full Text] [Related]
10. Intestinal CREBH overexpression prevents high-cholesterol diet-induced hypercholesterolemia by reducing
Kikuchi T; Orihara K; Oikawa F; Han SI; Kuba M; Okuda K; Satoh A; Osaki Y; Takeuchi Y; Aita Y; Matsuzaka T; Iwasaki H; Yatoh S; Sekiya M; Yahagi N; Suzuki H; Sone H; Nakagawa Y; Yamada N; Shimano H
Mol Metab; 2016 Nov; 5(11):1092-1102. PubMed ID: 27818935
[TBL] [Abstract][Full Text] [Related]
11. Genetic variation in ABC G5/G8 and NPC1L1 impact cholesterol response to plant sterols in hypercholesterolemic men.
Zhao HL; Houweling AH; Vanstone CA; Jew S; Trautwein EA; Duchateau GS; Jones PJ
Lipids; 2008 Dec; 43(12):1155-64. PubMed ID: 18850127
[TBL] [Abstract][Full Text] [Related]
12. Cooperative interaction between hepatocyte nuclear factor 4 alpha and GATA transcription factors regulates ATP-binding cassette sterol transporters ABCG5 and ABCG8.
Sumi K; Tanaka T; Uchida A; Magoori K; Urashima Y; Ohashi R; Ohguchi H; Okamura M; Kudo H; Daigo K; Maejima T; Kojima N; Sakakibara I; Jiang S; Hasegawa G; Kim I; Osborne TF; Naito M; Gonzalez FJ; Hamakubo T; Kodama T; Sakai J
Mol Cell Biol; 2007 Jun; 27(12):4248-60. PubMed ID: 17403900
[TBL] [Abstract][Full Text] [Related]
13. Genetic inactivation of NPC1L1 protects against sitosterolemia in mice lacking ABCG5/ABCG8.
Tang W; Ma Y; Jia L; Ioannou YA; Davies JP; Yu L
J Lipid Res; 2009 Feb; 50(2):293-300. PubMed ID: 18796403
[TBL] [Abstract][Full Text] [Related]
14. Liver-specific induction of Abcg5 and Abcg8 stimulates reverse cholesterol transport in response to ezetimibe treatment.
Altemus JB; Patel SB; Sehayek E
Metabolism; 2014 Oct; 63(10):1334-41. PubMed ID: 25060694
[TBL] [Abstract][Full Text] [Related]
15. TTC39B deficiency stabilizes LXR reducing both atherosclerosis and steatohepatitis.
Hsieh J; Koseki M; Molusky MM; Yakushiji E; Ichi I; Westerterp M; Iqbal J; Chan RB; Abramowicz S; Tascau L; Takiguchi S; Yamashita S; Welch CL; Di Paolo G; Hussain MM; Lefkowitch JH; Rader DJ; Tall AR
Nature; 2016 Jul; 535(7611):303-7. PubMed ID: 27383786
[TBL] [Abstract][Full Text] [Related]
16. Purification and ATP hydrolysis of the putative cholesterol transporters ABCG5 and ABCG8.
Wang Z; Stalcup LD; Harvey BJ; Weber J; Chloupkova M; Dumont ME; Dean M; Urbatsch IL
Biochemistry; 2006 Aug; 45(32):9929-39. PubMed ID: 16893193
[TBL] [Abstract][Full Text] [Related]
17. Coexpression of ATP-binding cassette proteins ABCG5 and ABCG8 permits their transport to the apical surface.
Graf GA; Li WP; Gerard RD; Gelissen I; White A; Cohen JC; Hobbs HH
J Clin Invest; 2002 Sep; 110(5):659-69. PubMed ID: 12208867
[TBL] [Abstract][Full Text] [Related]
18. NPC2 regulates biliary cholesterol secretion via stimulation of ABCG5/G8-mediated cholesterol transport.
Yamanashi Y; Takada T; Yoshikado T; Shoda J; Suzuki H
Gastroenterology; 2011 May; 140(5):1664-74. PubMed ID: 21315718
[TBL] [Abstract][Full Text] [Related]
19. Sterol transporters: targets of natural sterols and new lipid lowering drugs.
Sudhop T; Lütjohann D; von Bergmann K
Pharmacol Ther; 2005 Mar; 105(3):333-41. PubMed ID: 15737409
[TBL] [Abstract][Full Text] [Related]
20. Localization of ABCG5 and ABCG8 proteins in human liver, gall bladder and intestine.
Klett EL; Lee MH; Adams DB; Chavin KD; Patel SB
BMC Gastroenterol; 2004 Sep; 4():21. PubMed ID: 15383151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
